03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Eloxatine 100mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Aventis |
Origin | France |
Manufacturer | Sanofi Aventis Deutschland GmbH |
Origin | Germany |
ATC | L01XA03 |
Eloxatine 100mg* :
Eloxatine 100mg* :
Eloxatine 100mg* :
Eloxatine 100mg* :
Eloxatine 100mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Eloxatine 100mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Allergic reaction | Very Common |
Allergy | Very Common |
Alopecia | Very Common |
Anaemia | Very Common |
Anorexia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Very Common |
Back pain | Very Common |
Blindness transient (Temporary vision loss) | Rare |
Blood alkaline phosphatase increased | Very Common |
Blood lactate dehydrogenase increased | Very Common |
Bone pain | Common |
Cephalea | Very Common |
Colitis | Rare |
Conjunctivitis | Common |
Constipation | Very Common |
Cough | Very Common |
Creatinine increased | Common |
Deafness | Rare |
Deep vein thrombosis | Common |
Dehydration | Common |
Depression | Common |
Diarrhoea (Diarrhea) | Very Common |
Diarrhoea, Clostridium difficile | Rare |
Dizzy spells | Common |
Dysarthria | Rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Very Common |
Dysuria (Micturition painful) | Common |
Epistaxis (Nasal bleeding) | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Fever | Very Common |
Flushing | Common |
Gastrointestinal bleeding | Common |
Gastrooesophageal reflux disease | Common |
Haematuria (Hematuria) | Common |
Haemolytic anemia | Rare |
Haemorrhage | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Hepatic enzyme increased | Very Common |
Hiccups | Common |
Hyperglycaemia | Very Common |
Hyperhidrosis | Common |
Hypernatraemia | Very Common |
Hypertension | Common |
Hypokalaemia | Very Common |
Ileus | Uncommon |
Immune-mediated thrombocytopenia | Rare |
Infection | Very Common |
Injection site reaction | Very Common |
Insomnia | Common |
Interstitial pneumonia | Rare |
Intestinal obstruction | Uncommon |
Leucopenia (Leukopenia) | Very Common |
Lymphopenia | Very Common |
Meningism | Common |
Metabolic acidosis | Uncommon |
Mucositis | Very Common |
Nail disorders | Common |
Nausea postoperative | Very Common |
Nervousness | Uncommon |
Neuritis motor | Common |
Neutropenia | Very Common |
Neutropenic sepsis | Common |
Optic neuritis | Rare |
Ototoxicity | Uncommon |
Pain | Very Common |
Pancreatitis | Rare |
Peripheral sensory neuropathy | Very Common |
Posterior reversible leukoencephalopathy syndrome (PRES) | Rare |
Pulmonary embolism | Common |
Pulmonary fibrosis | Rare |
Rash erythematous | Common |
Rectal haemorrhage | Common |
Rhinitis | Common |
Sensory disturbance | Very Common |
Sepsis (Systemic infection) (Sepsis state) | Uncommon |
Serum bilirubin increased | Very Common |
Skin disorders | Very Common |
Skin rash | Common |
Stomatitis | Very Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Upper respiratory tract infection | Common |
Urinary frequency altered | Common |
Visual acuity reduced | Rare |
Visual disturbance | Common |
Visual field defect | Rare |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
Weight increased (weight gain) | Very Common |
Eloxatine 100mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Eloxatine 100mg* MoH 5550 :
Form | Concentrate for solution for infusion |
Packaging | Bottle (Glass) |
Package Size | 1x20ml |
Strength | 100mg |
Storage Condition | <30°C protect from light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 218024/09 |
Submission date | 01/01/2009 |
Registration Year | 2009 |
Archived Date | 2014 |
Price Comparison
● Country: | Italy | |
● Package Size: | 1x20ml | |
● Public Price: | 581.77 EUR | ( 56,359,550.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 581,77 EUR | ( 56,284,956.00 LBP ) |
● Exfactory Price: | 352.5 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 20ml Bottle | |
● Public Price: | 2145 QAR | ( 52,676,910.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2145 QAR | ( 52,676,910.00 LBP ) |
● Pharmacy Price: | 1761.9099147 QAR | ( 43268983.685203 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 1x20ml | |
● Public Price: | 225.84 OMR | ( 52,108,966.56 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 225,84 OMR | ( 51,915,150.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | 20ml | |
● Public Price: | 175.98 KWD | ( 51,664,384.38 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 175,98 KWD | ( 51,376,675.00 LBP ) |
● Pharmacy Price: | 148.67 KWD | ( 43646687.27 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 20ml Glass Vial | |
● Public Price: | 2004 AED | ( 48,418,644.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2004 AED | ( 48,418,644.00 LBP ) |
● Pharmacy Price: | 1707.41 AED | ( 41252733.01 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 20ml Glass Vial | |
● Public Price: | 2004 AED | ( 48,418,644.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2004 AED | ( 48,418,644.00 LBP ) |
● Pharmacy Price: | 1707.41 AED | ( 41252733.01 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 1x20ml | |
● Public Price: | 190.64 BHD | ( 45,321,609.76 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 190,64 BHD | ( 45,169,460.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 04/07/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 1835.65 SAR | ( 43,394,766.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1835,65 SAR | ( 43,379,400.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 20ml | |
● Public Price: | 237.05 CHF | ( 24,515,711.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 237,05 CHF | ( 24,510,540.00 LBP ) |
● Exfactory Price: | 192.22 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1x20ml | |
● Public Price: | 141.94 EUR | ( 13,750,579.44 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 141,94 EUR | ( 13,659,516.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 02/11/2018 | |
● Type: | Medicine Non Marketed |
● Country: | Belgium | |
● Package Size: | 1x20ml | |
● Public Price: | 74 EUR | ( 7,168,824.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 74 EUR | ( 7,168,824.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 1024.38 TRY | ( 2,745,338.40 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1024,38 TRY | ( 2,744,320.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 1x20ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | UK |
● Package Size: | 1x20ml |
● Reference: | DMD |
● Pricing Date: | 08/03/2021 |
● Type: | Medicine Withdrawn |
Note
You have to register to view this info
Drop File